Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumour immunology, vaccination and escape strategies.

European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics - 1 Jun 2003

García-Lora A, Algarra I, Collado A, Garrido F

Abstract excerpt

Our increasing knowledge of the mechanisms by which tumour cells escape immune effector cells is helping to establish new approaches to therapeutic vaccination against tumour development. One of the escape mechanisms used by tumour cells is the generation of multiple variants with different HLA p...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Tumor Escape
Share to HLA-C Antigens
Share to Antigens, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer Vaccines

Share to Genes, MHC Class I

Share to HLA-B Antigens

Share to Up-Regulation

Share to Vaccination

Source

Identifiers

PMID: 12786993
DOI: 10.1046/j.1365-2370.2003.00384.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12786993-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumour immunology, vaccination and escape strategies.PMID 12786993Read ↗

The biological consequences of altered MHC class I expression in tumours.Semantic proximity Read ↗

MHC antigens and tumor escape from immune surveillance.Semantic proximity Read ↗

Cancer immune escape: MHC expression in primary tumours versus metastasesSemantic proximity Read ↗

The HLA crossroad in tumor immunology.Semantic proximity Read ↗

HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activationSemantic proximity Read ↗

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.Semantic proximity Read ↗

Targeting HLA class I expression to increase tumor immunogenicitySemantic proximity Read ↗

Mechanisms of Tumor and Viral Immune Escape from Natural Killer Cell-Mediated SurveillanceSemantic proximity Read ↗

Tumour MHC class I downregulation and immunotherapy (Review).Semantic proximity Read ↗

Vaccination with T cell-defined antigens.Semantic proximity Read ↗

Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms.Semantic proximity Read ↗

Altered MHC class I antigens in tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.